文献速递产科母胎医学

一次妊娠期糖尿病,终身妊娠期糖尿病?前次妊娠期糖尿病而本次非妊娠期糖尿病妊娠的母婴结局:一项回顾性队列研究

Once gestational diabetes, always gestational diabetes? Maternal and neonatal outcomes of pregnancies with gestational diabetes preceding nongestational diabetes pregnancy: a retrospective cohort study.
PubMed 文献 · Am J Obstet Gynecol · 2025-07-09

这项回顾性队列研究纳入2012年7月至2022年12月在同一三级医疗中心至少连续分娩2次的19703例个体,比较两次妊娠均诊断妊娠期糖尿病(组1)、仅首次妊娠诊断而后续妊娠未诊断(组2)及两次均未诊断(组3)的糖尿病相关并发症。组2的巨大儿、大于胎龄儿和子痫前期发生率高于组3,组1与组2的大于胎龄儿、巨大儿和子痫前期发生率相似。结论认为前次有妊娠期糖尿病史而后续妊娠未诊断者仍存在糖尿病相关并发症风险升高。

要点

  • 前次妊娠期糖尿病而后续妊娠未诊断者,巨大儿、大于胎龄儿和子痫前期风险仍高于无妊娠期糖尿病者。
  • 两次均诊断者的母婴复合不良结局升高更明显,调整后OR为1.75。
  • 前次有妊娠期糖尿病史而后续未诊断者,其未诊断并不消除不良结局风险。

核心结论

  • 前次妊娠有妊娠期糖尿病史而后续妊娠未诊断者,发生子痫前期、巨大儿和大于胎龄儿的糖尿病相关并发症风险升高。
  • 作者认为这些个体可能存在潜在的胰岛素抵抗和其他持续存在的危险因素,其未诊断妊娠期糖尿病并不消除不良结局风险。

研究设计与样本

  • 采用回顾性队列设计,纳入2012年7月至2022年12月在同一三级医疗中心至少连续分娩2次的个体。
  • 研究人群共19703例,分为3组:两次妊娠均诊断妊娠期糖尿病(组1)、首次妊娠诊断而后续妊娠未诊断(组2)、两次均未诊断(组3)。
  • 比较各组多种糖尿病相关并发症。

主要发现

  • 组2巨大儿发生率高于组3,OR 1.40(95%CI 1.01-1.92),P=.03。
  • 组2大于胎龄儿发生率高于组3,OR 1.60(95%CI 1.20-2.00),P<.01。
  • 组2子痫前期发生率高于组3,OR 2.35(95%CI 1.32-4.15),P<.01。
  • 组1与组2的大于胎龄儿、巨大儿和子痫前期发生率相似。
  • 母婴复合不良结局在组1和组2均显著高于组3,OR分别为1.48(95%CI 1.23-1.77,P<.01)和1.91(95%CI 1.58-2.3,P<.01)。

关键数值与推荐

  • 选择性剖宫产率组1为22%、组2为13%,均高于组3的8.7%;组1也显著高于组2。
  • 与组3相比,组1早产率升高,OR 1.70(95%CI 1.20-2.30),P<.01;组2早产率与组3相比未见升高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is limited information about maternal and neonatal outcomes of pregnant individuals without gestational diabetes mellitus who were diagnosed with gestational diabetes mellitus in the preceding pregnancy. OBJECTIVE: This study aimed to investigate whether individuals previously diagnosed with gestational diabetes mellitus but not in subsequent pregnancy present similar diabetes-related complications despite the lack of diagnosis. STUDY DESIGN: A retrospective cohort design was employed, including individuals with at least 2 consecutive births at a tertiary medical center between July 2012 and December 2022. Participants were categorized into 3 groups: individuals with gestational diabetes mellitus in both pregnancies (group 1), individuals with gestational diabetes mellitus in the first pregnancy but not in the subsequent pregnancy (group 2), and individuals with no gestational diabetes mellitus in both pregnancies (group 3). The groups were compared for various diabetes-related complications. RESULTS: The study population was composed of 19,703 individuals. Group 2 showed higher rates of macrosomia (odds ratio, 1.40 [95% confidence interval, 1.01-1.92]; P=.03), large for gestational age (odds ratio, 1.60 [95% confidence interval, 1.20-2.00]; P<.01), and preeclampsia (odds ratio, 2.35 [95% confidence interval, 1.32-4.15]; P<.01) than group 3. The rates of large for gestational age, macrosomia, and preeclampsia were similar between groups 1 and 2. The composite maternal-neonatal adverse outcome was significantly elevated in groups 1 and 2 than in group 3 (odds ratios: 1.48 [95% confidence interval, 1.23-1.77; P<.01] and 1.91 [95% confidence interval, 1.58-2.3; P<.01], respectively). In a multivariate regression analysis, the adjusted odds ratios (accounting for a body mass index before the second birth, age at the second birth, and parity) for composite maternal-neonatal outcomes were 1.75 (95% confidence interval, 1.36-2.25; P<.01) in group 1 and 1.30 (95% confidence interval, 1.01-1.67; P=.03) in group 2 compared with group 3. The elective cesarean delivery rate was higher in groups 1 (22%) and 2 (13%) than in group 3 (8.7%). However, the rate was also significantly higher in group 1 than in group 2. The preterm birth rates were higher in group 1 (odds ratio, 1.70 [95% confidence interval, 1.20-2.30]; P<.01) but not in group 2 compared with group 3. CONCLUSION: Individuals with a history of gestational diabetes mellitus in a previous pregnancy but not in subsequent pregnancy are at increased risk of diabetes-related complications, including preeclampsia, macrosomia, and large for gestational age. Our findings suggest that these individuals may have underlying insulin resistance and other, still occurring, risk factors, and their absence of a gestational diabetes mellitus diagnosis does not eliminate the risk of adverse outcomes.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Shalev-Rosenthal Y, Hadar E, Rosenthal A, et al. Once gestational diabetes, always gestational diabetes? Maternal and neonatal outcomes of pregnancies with gestational diabetes preceding nongestational diabetes pregnancy: a retrospective cohort study. Am J Obstet Gynecol. 2025. PMID: 40645473. doi:10.1016/j.ajog.2025.07.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。